Effect of nitroxyl on human platelets function. 2005

Emilse Bermejo, and Daniel A Sáenz, and Fabiana Alberto, and Ruth E Rosenstein, and Sara E Bari, and María A Lazzari
Departamento de Bioquímica Humana, Facultad de Medicina, Universidad de Buenos Aires, Argentina.

There is a growing body of evidence on the role of nitric oxide (NO) in human platelet physiology regulation. Recently, interest has developed in the functional role of an alternative redox form of NO, namely nitroxyl (HNO/NO-), because it is formed by a number of diverse biochemical reactions. The aim of the present study was to comparatively analyze the effect of HNO and NO on several functional parameters of human platelets. For this purpose, sodium trioxodinitrate (Angeli's salt,AS) and sodium nitroprusside (SNP) were used as HNO and NO releasers, respectively. BothAS and SNP significantly inhibited platelet aggregation and ATP release induced by different agonists and adrenaline. AS or SNP did not modify the expression of platelet glycoproteins (Ib, IIb-IIIa, la-IIa, IV), whereas they substantially decreased the levels of CD62P, CD63 and of PAC-1 (a platelet activated glycoprotein IIb/IIIa epitope) after the stimulation with ADP. AS and SNP significantly increased cGMP accumulation in a 1H-[1,2,4]oxadiazolo [4,3-a] quinoxalin-1-one (ODQ)-sensitive manner. However, while L-cysteine reduced the effect of AS, it increased the effect of SNP on this parameter. Accordingly, a differential effect of L-cysteine was observed on the antiaggregatory effect of both compounds. In summary, these results indicate that HNO is an effective inhibitor of human platelet aggregation.

UI MeSH Term Description Entries
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite
D009589 Nitrogen Oxides Inorganic oxides that contain nitrogen. Nitrogen Oxide,Oxide, Nitrogen,Oxides, Nitrogen
D009599 Nitroprusside A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins. Nitroferricyanide,Sodium Nitroprusside,Cyanonitrosylferrate,Ketostix,Naniprus,Nipride,Nipruton,Nitriate,Nitropress,Nitroprussiat Fides,Nitroprusside, Disodium Salt,Nitroprusside, Disodium Salt, Dihydrate,Disodium Salt Nitroprusside,Nitroprusside, Sodium
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010980 Platelet Membrane Glycoproteins Surface glycoproteins on platelets which have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. Many of these are receptors. PM-GP,Platelet Glycoprotein,Platelet Membrane Glycoprotein,PM-GPs,Platelet Glycoproteins,Glycoprotein, Platelet,Glycoprotein, Platelet Membrane,Glycoproteins, Platelet,Glycoproteins, Platelet Membrane,Membrane Glycoprotein, Platelet,Membrane Glycoproteins, Platelet,PM GP
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug

Related Publications

Emilse Bermejo, and Daniel A Sáenz, and Fabiana Alberto, and Ruth E Rosenstein, and Sara E Bari, and María A Lazzari
May 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Emilse Bermejo, and Daniel A Sáenz, and Fabiana Alberto, and Ruth E Rosenstein, and Sara E Bari, and María A Lazzari
January 1972, Acta Universitatis Carolinae. Medica. Monographia,
Emilse Bermejo, and Daniel A Sáenz, and Fabiana Alberto, and Ruth E Rosenstein, and Sara E Bari, and María A Lazzari
October 1990, Sheng li ke xue jin zhan [Progress in physiology],
Emilse Bermejo, and Daniel A Sáenz, and Fabiana Alberto, and Ruth E Rosenstein, and Sara E Bari, and María A Lazzari
December 1978, Thrombosis research,
Emilse Bermejo, and Daniel A Sáenz, and Fabiana Alberto, and Ruth E Rosenstein, and Sara E Bari, and María A Lazzari
August 1968, Lancet (London, England),
Emilse Bermejo, and Daniel A Sáenz, and Fabiana Alberto, and Ruth E Rosenstein, and Sara E Bari, and María A Lazzari
June 1968, Lancet (London, England),
Emilse Bermejo, and Daniel A Sáenz, and Fabiana Alberto, and Ruth E Rosenstein, and Sara E Bari, and María A Lazzari
May 1968, Lancet (London, England),
Emilse Bermejo, and Daniel A Sáenz, and Fabiana Alberto, and Ruth E Rosenstein, and Sara E Bari, and María A Lazzari
August 1968, Lancet (London, England),
Emilse Bermejo, and Daniel A Sáenz, and Fabiana Alberto, and Ruth E Rosenstein, and Sara E Bari, and María A Lazzari
January 1977, Haemostasis,
Emilse Bermejo, and Daniel A Sáenz, and Fabiana Alberto, and Ruth E Rosenstein, and Sara E Bari, and María A Lazzari
March 2018, Tuberculosis (Edinburgh, Scotland),
Copied contents to your clipboard!